Sherbrooke Park Advisers’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,168
| Closed | -$29.1K | – | 681 |
|
|
2025
Q1 | $29.1K | Sell |
13,168
-1,190
| -8% | -$2.63K | 0.01% | 562 |
|
|
2024
Q4 | $78.3K | Buy |
+14,358
| New | +$78.3K | 0.03% | 691 |
|
|
2024
Q1 | – | Sell |
-38,247
| Closed | -$251K | – | 947 |
|
|
2023
Q4 | $251K | Buy |
38,247
+23,976
| +168% | +$157K | 0.12% | 282 |
|
|
2023
Q3 | $143K | Buy |
+14,271
| New | +$143K | 0.05% | 427 |
|
|
2023
Q1 | – | Sell |
-16,900
| Closed | -$242K | – | 276 |
|
|
2022
Q4 | $242K | Buy |
+16,900
| New | +$242K | 0.18% | 221 |
|